Vermillion Inc. (VRML) and its subsidiaries engage in the discovery, development, and commercialization of diagnostics tests that help physicians to diagnose and treat patients. The Company develops novel diagnostic tests in the fields of oncology, hematology, cardiology, and women’s health with the initial focus on ovarian cancer. Its lead product includes the OVA1 ovarian tumor triage test (the OVA1 Test), which addresses pre-surgical identification of women who are at high risk of having a malignant ovarian tumor. The Company has collaborations with various academic and research institutions, including The Johns Hopkins University School of Medicine; The University of Texas M.D. Anderson Cancer Center; University College London; The University of Texas Medical Branch; The Katholieke Universiteit Leuven; Clinic of Gynecology and Clinic of Oncology, Rigshospitalet; Copenhagen University Hospital; The Ohio State University Research Foundation; Stanford University; and the University of Kentucky. It also has strategic alliance agreement with Quest Diagnostics Inc. to develop and commercialize up to three diagnostic tests. VRML serves clinical reference laboratories, hospital laboratories and physician offices.

Source: Reuters.com, SEC Filings.

Investment Highlights

VRML shares headed higher on Tuesday after the Company announced its fourth quarter and full year 2011 results, which showed strong increases in total revenues and lower net losses.

Shares in the Austin, TX-based company added 12.03% to close at $1.77, with over 2.52 million shares traded.  The stock has so far reached a 52-week high of $7.60, its 52-week low being $0.97.

Shares have risen 11.3% in the last five trading days and 37.2% in the last month.  Year-to-date, the stock is down 62.1%.

Total revenues in the December quarter rose 152% to $868K from $345K in the comparable quarter of the previous year.  The latest quarterly result included included $755K from product sales of OVA1, the Company’s flagship diagnostic designed to help differentiate benign from malignant ovarian masses, and $113K of license revenue related to the VRML’s achievement of certain milestones under its amended strategic alliance agreement with Quest Diagnostics.

For the full year, total revenues were $1.9 million, an increase of 64% from fiscal 2010. Full-year 2011 revenues included $1.5 million from product sales of OVA1 and $454K of license revenue. Product sales of OVA1 in 2011 include $761K from 15,225 OVA1 tests performed at the fixed $50 per test, $549K for the 33% royalty reported by Quest Diagnostics for 2011, and $159K for the 33% royalties reported by Quest Diagnostics for 2010. The 2010 royalty was reported to the company and recorded in the first quarter of 2011.

VRML realized a net loss $3.1 million, or $(0.21) per share, for the last three months of 2011, as compared to $4.0 million, or $(0.38) per share, in the same year-ago quarter. Net loss for 2010 included $8.6 million in reorganization items and $4.4 million in gains resulting from the exercise and fair value revaluation of common stock warrants. Net loss for 2011 came in at $17.8 million, or $(1.25) per share, as compared to $19.0 million, or $(1.83) per share in 2010.

As of December 31, 2011, VRML’s cash and cash equivalents totaled $22.5 million. The Company used $5.0 million in cash from operations during the fourth quarter, including $435,000 for the Correlogic asset acquisition.

Gail S. Page, president and CEO of VRML, made the following statements: “2011 showed substantial expansion in OVA1 tests usage leading to another year of revenue growth for Vermillion.  In fact, more than 3,700 or 11% of the nation’s gynecologists — the professionals who help define the standard of care for women with ovarian cancer — ordered OVA1 in 2011. The specialist sub-group of gynecologic oncologists supporting OVA1 also grew by 24 in the fourth quarter, bringing the total to more than 275. Given the relatively short period of time this test has been on the market, this represents strong traction and increasing brand awareness within the gynecologist community. This strong progress was matched by increased OVA1 payer coverage in 2011 and the addition of the Department of Defense payer coverage in January 2012.”

VRML earlier this month announced the American Medical Association (AMA) Current Procedural Terminology (CPT) Panel has voted to approve an application for a Category 1 CPT code for its OVA1 test.  According to CEO Page, this approval was supported by several peer-reviewed publications and positive coverage decisions, including Medicare.

“The new CPT code is a critical step in advancing the commercialization of OVA1, as we believe it will help streamline claims processing and accelerate further coverage and adoption by private payers.”

Source:

http://phx.corporate-ir.net/preview/phoenix.zhtml?c=121814&p=irol-news&nyo=0

Technical Analysis

Source: http://stockcharts.com

VRML is within its Bollinger Bands. This is a normal condition suggesting that it is neither overbought nor oversold relative to the recent levels.

VRML’s MACD is indicating a weak bearish signal. Although the indicator is above the critical level of 0, which implies that the underlying moving averages are bullish, the MACD has crossed below its 9minute moving average or signal line. This suggests that positive momentum has begun to slow.

Comparative Analysis

Source: Thomson Financial

DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND ON THIS REPORT. We are not registered as a securities broker-dealer or an investment adviser either with the U.S. Securities and Exchange Commission (the “SEC”) or with any state securities regulatory authority.  We are neither licensed nor qualified to provide investment advice.

The information contained in our report should be viewed as commercial advertisement and is not intended to be investment advice.  The report is not provided to any particular individual with a view toward their individual circumstances. The information contained in our report is not an offer to buy or sell securities.  We distribute opinions, comments and information free of charge exclusively to individuals who wish to receive them.

Our newsletter and website have been prepared for informational purposes only and are not intended to be used as a complete source of information on any particular company.  An individual should never invest in the securities of any of the companies profiled based solely on information contained in our report.  Individuals should assume that all information contained in the report about profiled companies is not trustworthy unless verified by their own independent research.

Any individual who chooses to invest in any securities should do so with caution.  Investing in securities is speculative and carries a high degree of risk; you may lose some or all of the money that is invested.  Always research your own investments and consult with a registered investment advisor or licensed stock broker before investing.

Information contained in our report will contain “forward looking statements” as defined under Section 27A of the Securities Act of 1933 and Section 21B of the Securities Exchange Act of 1934.  Subscribers are cautioned not to place undue reliance upon these forward looking statements.  These forward looking statements are subject to a number of known and unknown risks and uncertainties outside of our control that could cause actual operations or results to differ materially from those anticipated.  Factors that could affect performance include, but are not limited to, those factors that are discussed in each profiled company’s most recent reports or registration statements filed with the SEC.  You should consider these factors in evaluating the forward looking statements included in the report and not place undue reliance upon such statements.

We are committed to providing factual information on the companies that are profiled.  However, we do not provide any assurance as to the accuracy or completeness of the information provided, including information regarding a profiled company’s plans or ability to effect any planned or proposed actions.  We have no first-hand knowledge of any profiled company’s operations and therefore cannot comment on their capabilities, intent, resources, nor experience and we make no attempt to do so.  Statistical information, dollar amounts, and market size data was provided by the subject company and related sources which we believe to be reliable.

To the fullest extent of the law, we will not be liable to any person or entity for the quality, accuracy, completeness, reliability, or timeliness of the information provided in the report, or for any direct, indirect, consequential, incidental, special or punitive damages that may arise out of the use of information we provide to any person or entity (including, but not limited to, lost profits, loss of opportunities, trading losses, and damages that may result from any inaccuracy or incompleteness of this information).

We encourage you to invest carefully and read investment information available at the websites of the SEC at http://www.sec.gov and FINRA at http://www.finra.org.

No related posts.

XOMA Corp. (XOMA) engages in the discovery and development of innovative antibody therapeutics. The Company’s lead antibody drug candidate is gevokizumab (XOMA 052), a humanized antibody that modulates the inflammatory cytokine interleukin-1 beta, or IL-1 beta. In collaboration with the Company’s partner, Les Laboratoires Servier (Servier), XOMA expects to initiate global Phase III clinical development of gevokizumab to treat non-infectious uveitis, including the subset of patients with Behcet’s uveitis, in 2012. Separately, XOMA has launched a Phase II proof-of-concept program for gevokizumab to evaluate additional indications for further development, including moderate-to-severe inflammatory acne.

Source: Reuters.com, SEC Filings.

Investment Highlights

Shares in XOMA have gained 17.7% in the last five trading days and 76.1% in the last month. Year-to-date, shares have dropped 17.0%.

Shares in the Berkeley, CA-based antibody therapeutics company advanced over 15% to close Tuesday trade at $2.73.  Over 4 million shares exchanged hands during the session, topping the 10-day average of over 904K. The stock has a 52-week range of $1.04 – $3.49.

XOMA earlier this month announced its results for the December quarter and the full year 2011, showing increases in revenues.

XOMA recorded total revenues of $9.8 million for the fourth quarter ended December 31, 2011, compared with total revenues of $9.6 million for the quarter ended December 31, 2010.  For the full year, the company reported total revenues of $58.2 million, up from $33.6 million in 2010, and is primarily attributable to payments made by Les Laboratoires Servier (Servier) throughout 2011 for gevokizumab development.

The Company realized a net loss of $11.7 million, or $0.34 per share, for the quarter, narrowing a net loss of $17.8 million, or $0.84 per share, in the comparable period of the previous year.  For the full year the Company recorded a net loss of $32.7 million, or $1.04 per share, an improvement from a net loss of $68.8 million, or $3.69 per share, for the year ended December 31, 2010.

XOMA’s cash and cash equivalents totaled $48.3 million at December 31, 2011, compared with $37.3 million at December 31, 2010. The Company received from Servier approximately $35 million in cash related to the companies’ Collaboration and License Agreement for gevokizumab, including an upfront payment of $15 million and a EUR15 million loan, in January 2011. In December 2011, XOMA secured a $10 million loan from GE Capital.

Source:

http://investors.xoma.com/releasedetail.cfm?ReleaseID=657321

Technical Analysis

Source: http://stockcharts.com

XOMA is above the upper Bollinger Band, implying that it is currently extended from its recent trend. Be aware, however, that a cross outside of the Bollinger Bands can sometimes be a signal of trend strength and not, necessarily, trend reversal.

The MACD for XOMA currently indicates a strong bullish signal for two reasons. First, the MACD is above the signal line, a 9-day moving average. Second, the MACD is above 0, which implies that the underlying moving averages are trending higher.

Comparative Analysis

Source: Thomson Financial

DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND ON THIS REPORT. We are not registered as a securities broker-dealer or an investment adviser either with the U.S. Securities and Exchange Commission (the “SEC”) or with any state securities regulatory authority.  We are neither licensed nor qualified to provide investment advice.

The information contained in our report should be viewed as commercial advertisement and is not intended to be investment advice.  The report is not provided to any particular individual with a view toward their individual circumstances. The information contained in our report is not an offer to buy or sell securities.  We distribute opinions, comments and information free of charge exclusively to individuals who wish to receive them.

Our newsletter and website have been prepared for informational purposes only and are not intended to be used as a complete source of information on any particular company.  An individual should never invest in the securities of any of the companies profiled based solely on information contained in our report.  Individuals should assume that all information contained in the report about profiled companies is not trustworthy unless verified by their own independent research.

Any individual who chooses to invest in any securities should do so with caution.  Investing in securities is speculative and carries a high degree of risk; you may lose some or all of the money that is invested.  Always research your own investments and consult with a registered investment advisor or licensed stock broker before investing.

Information contained in our report will contain “forward looking statements” as defined under Section 27A of the Securities Act of 1933 and Section 21B of the Securities Exchange Act of 1934.  Subscribers are cautioned not to place undue reliance upon these forward looking statements.  These forward looking statements are subject to a number of known and unknown risks and uncertainties outside of our control that could cause actual operations or results to differ materially from those anticipated.  Factors that could affect performance include, but are not limited to, those factors that are discussed in each profiled company’s most recent reports or registration statements filed with the SEC.  You should consider these factors in evaluating the forward looking statements included in the report and not place undue reliance upon such statements.

We are committed to providing factual information on the companies that are profiled.  However, we do not provide any assurance as to the accuracy or completeness of the information provided, including information regarding a profiled company’s plans or ability to effect any planned or proposed actions.  We have no first-hand knowledge of any profiled company’s operations and therefore cannot comment on their capabilities, intent, resources, nor experience and we make no attempt to do so.  Statistical information, dollar amounts, and market size data was provided by the subject company and related sources which we believe to be reliable.

To the fullest extent of the law, we will not be liable to any person or entity for the quality, accuracy, completeness, reliability, or timeliness of the information provided in the report, or for any direct, indirect, consequential, incidental, special or punitive damages that may arise out of the use of information we provide to any person or entity (including, but not limited to, lost profits, loss of opportunities, trading losses, and damages that may result from any inaccuracy or incompleteness of this information).

We encourage you to invest carefully and read investment information available at the websites of the SEC at http://www.sec.gov and FINRA at http://www.finra.org.

Related Articles

1. Stock Alert for XOMA Ltd. (XOMA)

Opnext Inc. (OPXT) designs and manufactures optical components, modules and subsystems for communications uses. The Company sells its products, which enables network connectivity to address the data usage by the global population, to other businesses. Additionally, it sells infrared and visible light optical devices for industrial and commercial use. Its optical communications components consist of discrete transmitters and receivers typically consisting of a hermetically packaged compound semiconductor laser or photodetector. These components utilize internally fabricated or externally sourced lasers or photodetectors built from indium phosphide (InP) or gallium arsenide (GaAs) compound semiconductor materials systems. The subsystems specialize in 40 gigabit per second and 100 gigabit per second long distance optical communications.

Source: Reuters.com, SEC Filings.

Investment Highlights

OPXT advanced over 53% to close Tuesday trade at $1.73, boosted by news the high-speed optical communications technology provider will be acquired by rival Oclaro Inc. (NASDAQ: OCLR) in a stock swap worth about $177 million. OPXT jumped to an intraday high of $1.74 as volume swelled to nearly 12 million shares.

Shares in OPXT have gained 58.7% in the last five days and 57.3% in the last month.  Year-to-date, the stock is down 26.7%.

According to the release, the merger is expected  to mark a major transformation in the optical industry and create a new industry leader in the fast-growing optical components and modules market, forecast to reach $9.2 billion in 2015. The broad product portfolio, technology innovation, engineering resources, cost structure and strategic customer relationships of the combined company are expected to expand its opportunities for growth and to create long-term shareholder value,  the companies said in a statement.

Under the deal, OPXT shareholders will receive a fixed ratio of 0.42 shares of OCLR common stock for every share of OPXTt common stock they own.

The combined company is expected to achieve positive non-GAAP operating income in the first full quarter after the close and is expected to achieve annualized cost synergies of $35 million to $45 million within 18 months of the close of the transaction. OPXT expects restructuring and system integration costs to total $20 million to $30 million.

Source:

http://finance.yahoo.com/news/oclaro-opnext-agree-merge-202300058.html

Financial Summary

OPXT posted revenue of $53.1 million for the third fiscal quarter ended December 31, 2011, down 38.3% sequentially and down 45.3% compared to the quarter ended December 31, 2010.  The Company attributed the decline to the loss of production capacity at Fabrinet, its contract manufacturer in Thailand, following the flooding in October 2011.

On a non-GAAP basis, the Company reported an operating loss of $21.5 million for the December quarter, up from $7.1 million in the September quarter. Net loss was $46.3 million, or negative $0.51 per fully diluted share, compared to a net loss of $10.0 million or negative $0.11 per share in the September quarter.

Non-GAAP net loss came in at $21.6 million, $0.24 per fully diluted share, compared to a loss of $6.5 million, or $0.07, in the September quarter. EBITDA was negative $38.9 million, compared to negative $1.5 million in the September quarter, and adjusted EBITDA was negative $16 million compared to positive about $100,000 in the September quarter.

OPXT’s Cash and cash equivalents totaled $85.2 million at December 31, 2011. Net of short-term debt, cash and cash equivalents were $65.7 million at December 31, 2011.

Source:

http://investor.opnext.com/releasedetail.cfm?ReleaseID=646987

Technical Analysis

Source: http://stockcharts.com

OPXT is above the upper Bollinger Band, implying that it is currently extended from its recent trend. Be aware, however, that a cross outside of the Bollinger Bands can sometimes be a signal of trend strength and not, necessarily, trend reversal.

The MACD for OPXT currently indicates a strong bullish signal for two reasons. First, the MACD is above the signal line, a 9-day moving average. Second, the MACD is above 0, which implies that the underlying moving averages are trending higher.

Comparative Analysis

Source: Thomson Financial

DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND ON THIS REPORT. We are not registered as a securities broker-dealer or an investment adviser either with the U.S. Securities and Exchange Commission (the “SEC”) or with any state securities regulatory authority.  We are neither licensed nor qualified to provide investment advice.

The information contained in our report should be viewed as commercial advertisement and is not intended to be investment advice.  The report is not provided to any particular individual with a view toward their individual circumstances. The information contained in our report is not an offer to buy or sell securities.  We distribute opinions, comments and information free of charge exclusively to individuals who wish to receive them.

Our newsletter and website have been prepared for informational purposes only and are not intended to be used as a complete source of information on any particular company.  An individual should never invest in the securities of any of the companies profiled based solely on information contained in our report.  Individuals should assume that all information contained in the report about profiled companies is not trustworthy unless verified by their own independent research.

Any individual who chooses to invest in any securities should do so with caution.  Investing in securities is speculative and carries a high degree of risk; you may lose some or all of the money that is invested.  Always research your own investments and consult with a registered investment advisor or licensed stock broker before investing.

Information contained in our report will contain “forward looking statements” as defined under Section 27A of the Securities Act of 1933 and Section 21B of the Securities Exchange Act of 1934.  Subscribers are cautioned not to place undue reliance upon these forward looking statements.  These forward looking statements are subject to a number of known and unknown risks and uncertainties outside of our control that could cause actual operations or results to differ materially from those anticipated.  Factors that could affect performance include, but are not limited to, those factors that are discussed in each profiled company’s most recent reports or registration statements filed with the SEC.  You should consider these factors in evaluating the forward looking statements included in the report and not place undue reliance upon such statements.

We are committed to providing factual information on the companies that are profiled.  However, we do not provide any assurance as to the accuracy or completeness of the information provided, including information regarding a profiled company’s plans or ability to effect any planned or proposed actions.  We have no first-hand knowledge of any profiled company’s operations and therefore cannot comment on their capabilities, intent, resources, nor experience and we make no attempt to do so.  Statistical information, dollar amounts, and market size data was provided by the subject company and related sources which we believe to be reliable.

To the fullest extent of the law, we will not be liable to any person or entity for the quality, accuracy, completeness, reliability, or timeliness of the information provided in the report, or for any direct, indirect, consequential, incidental, special or punitive damages that may arise out of the use of information we provide to any person or entity (including, but not limited to, lost profits, loss of opportunities, trading losses, and damages that may result from any inaccuracy or incompleteness of this information).

We encourage you to invest carefully and read investment information available at the websites of the SEC at http://www.sec.gov and FINRA at http://www.finra.org.

Related Articles

1. Stock Alert for Opnext Inc. (OPXT)
2. Stock Alert for Oclaro Inc. (OCLR)

Micron Technology Inc. (MU) is a provider of advanced semiconductor solutions. Through its worldwide operations, MU manufactures and markets a full range of DRAM, NAND Flash and NOR Flash memory, as well as other innovative memory technologies, packaging solutions and semiconductor systems for use in leading-edge computing, consumer, networking, embedded and mobile products.

Source: Reuters.com, SEC Filings.

Investment Highlights

Shares in MU slipped 1.79% to close Monday trade at $8.25, with nearly 36 million shares traded.  Over the last 52 weeks, the stock has ranged from a low of $3.97 to a high of $11.89.

MU shares have dropped 4.4% in the last five trading days; though the stock gained 3.8% in the last month.  Year-to-date, the stock is down 28.6%.

MU saw a spike earlier this month after the semiconductor technology company, together with Xilinx Inc. (NASDAQ: XLNX), announced the first public hardware demonstration of an FPGA interfacing with RLDRAM 3 memory, a new and emerging memory standard for high-end networking applications such as packet buffering and inspection, linked lists and lookup tables.

According to Derek Curd, technical marketing manager at Xilinx, the new RLDRAM 3 interface is ideal for Xilinx and MU’s mutual customers in the high-end networking space who require higher speed, higher density, lower power and lower latency. “The RLDRAM 3 hardware demonstration shows how we’re able to achieve a much more efficient transfer of network data.”

“Xilinx has been a longtime partner of Micron, going back to the early definition efforts of RLDRAM 3 memory,” stated Robert Feurle, vice president of Micron’s DRAM marketing. “Together, we welcome the ability to demonstrate and deliver performance advantages of RLDRAM 3 with the latest Virtex-7 and Kintex-7 families.”

MU also recently announced that it has developed a 2.5-inch enterprise solid-state drive (SSD) based on a PCIe interface. The solution combines a high-performance PCIe interface with a hot-swappable 2.5-inch form factor that creates new options for enterprise server performance scalability and serviceability.

Source:

http://investors.micron.com/releases.cfm

Financial Summary

MU reported net sales of $2.1 billion for its second quarter of fiscal 2012, compared to net sales of $2.1 billion for the first quarter of fiscal 2012, and net sales of $2.3 billion for the second quarter of fiscal 2011.

The Company’s consolidated gross margin dropped to 13% in the second quarter of fiscal 2012, compared to 15% for the first quarter of fiscal 2012, due primarily to declines in gross margins for the Company’s NOR Flash products in the wireless market. Sales of NOR Flash products were about11% of total net sales for the second quarter of fiscal 2012.

MU realized a net loss of $224 million, or $0.23 per diluted share, for the latest reported quarter, which compares to a net loss of $187 million, or $0.19 per diluted share, for the first quarter of fiscal 2012, and net income of $72 million, or $0.07 per diluted share, for the second quarter of fiscal 2011.

Cash flows from operations for the second quarter of fiscal 2012 were $574 million. During the second quarter of fiscal 2012, the Company invested approximately $429 million in capital expenditures. MU ended the second quarter with cash and short-term investments of $2.1 billion.

Source:

http://investors.micron.com/releasedetail.cfm?ReleaseID=658982

Technical Analysis

Source: http://stockcharts.com

MU is within its Bollinger Bands. This is a normal condition suggesting that it is neither overbought nor oversold relative to the recent levels.

MU’s MACD is indicating a weak bearish signal. Although the indicator is above the critical level of 0, which implies that the underlying moving averages are bullish, the MACD has crossed below its 9minute moving average or signal line. This suggests that positive momentum has begun to slow.

Comparative Analysis

Source: Thomson Financial

DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND ON THIS REPORT. We are not registered as a securities broker-dealer or an investment adviser either with the U.S. Securities and Exchange Commission (the “SEC”) or with any state securities regulatory authority.  We are neither licensed nor qualified to provide investment advice.

The information contained in our report should be viewed as commercial advertisement and is not intended to be investment advice.  The report is not provided to any particular individual with a view toward their individual circumstances. The information contained in our report is not an offer to buy or sell securities.  We distribute opinions, comments and information free of charge exclusively to individuals who wish to receive them.

Our newsletter and website have been prepared for informational purposes only and are not intended to be used as a complete source of information on any particular company.  An individual should never invest in the securities of any of the companies profiled based solely on information contained in our report.  Individuals should assume that all information contained in the report about profiled companies is not trustworthy unless verified by their own independent research.

Any individual who chooses to invest in any securities should do so with caution.  Investing in securities is speculative and carries a high degree of risk; you may lose some or all of the money that is invested.  Always research your own investments and consult with a registered investment advisor or licensed stock broker before investing.

Information contained in our report will contain “forward looking statements” as defined under Section 27A of the Securities Act of 1933 and Section 21B of the Securities Exchange Act of 1934.  Subscribers are cautioned not to place undue reliance upon these forward looking statements.  These forward looking statements are subject to a number of known and unknown risks and uncertainties outside of our control that could cause actual operations or results to differ materially from those anticipated.  Factors that could affect performance include, but are not limited to, those factors that are discussed in each profiled company’s most recent reports or registration statements filed with the SEC.  You should consider these factors in evaluating the forward looking statements included in the report and not place undue reliance upon such statements.

We are committed to providing factual information on the companies that are profiled.  However, we do not provide any assurance as to the accuracy or completeness of the information provided, including information regarding a profiled company’s plans or ability to effect any planned or proposed actions.  We have no first-hand knowledge of any profiled company’s operations and therefore cannot comment on their capabilities, intent, resources, nor experience and we make no attempt to do so.  Statistical information, dollar amounts, and market size data was provided by the subject company and related sources which we believe to be reliable.

To the fullest extent of the law, we will not be liable to any person or entity for the quality, accuracy, completeness, reliability, or timeliness of the information provided in the report, or for any direct, indirect, consequential, incidental, special or punitive damages that may arise out of the use of information we provide to any person or entity (including, but not limited to, lost profits, loss of opportunities, trading losses, and damages that may result from any inaccuracy or incompleteness of this information).

We encourage you to invest carefully and read investment information available at the websites of the SEC at http://www.sec.gov and FINRA at http://www.finra.org.

Related Articles

1. Stock Alert for Satcon Technology Corp. (SATC)
2. Stock Alert for Micro Imaging Technology Inc. (MMTC)
3. Alternative Energy Trade Option: Energy Conversion Devices Inc. (ENER) Review

Arena Pharmaceuticals Inc. (ARNA) is a clinical-stage biopharmaceutical company focused on discovering, developing and commercializing oral drugs that target G protein-coupled receptors, an important class of validated drug targets in four major therapeutic areas: cardiovascular, central nervous system, inflammatory and metabolic diseases. The Company’s most advanced drug candidate is lorcaserin, for weight management, which has completed a pivotal Phase III clinical trial program.

Source: Reuters.com, SEC Filings.

Investment Highlights

ARNA climbed as high as $3.19, a fresh 52-week high, following news the European Medicines Agency (EMA) has accepted the filing of a Marketing Authorization Application (MAA) for lorcaserin, ARNA’s drug candidate for weight management.  The acceptance of the MAA filing begins the EMA’s review process, the company said.  The stock closed Monday’s trade at $3.01, a gain of $0.60 on the day, with strong volume of nearly 59 million shares.

Shares in ARNA have jumped 66.3% in the last five days; 63.6% in the last month; and 107.6% year-to-date.

Investors also welcomed the news that the U.S. Food and Drug Administration (FDA) has confirmed the scheduling of an Endocrinologic and Metabolic Drugs Advisory Committee meeting to discuss the lorcaserin New Drug Application (NDA) resubmission on May 10, 2012.

Jack Lief, ARNA president and CEO, commented that with applications under review for approval in both the United States and European Union, lorcaserin has the potential to provide a new treatment for physicians to help patients lose weight and improve their overall cardiometabolic health.

ARNA  submitted a New Drug Application (NDA) for lorcaserin to the U.S. Food and Drug Administration (FDA) for regulatory approval in December 2009. The FDA then issued a complete response letter (CRL) in October 2010, outlining non-clinical and clinical reasons for its decision to not approve the drug, and provided recommendations relating to addressing the issues it raised in the CRL.  In January 2010, the Company completed an end-of-review meeting with the FDA for the locaserin NDA, which resulted in additional requirements.

It was earlier this year when ARNA, together with partner Eisai, announced that the FDA has accepted, for filing and review, its resubmission of the NDA for its obesity drug.

“We look forward to lorcaserin’s PDUFA date in June as well as reporting on developments related to the MAA throughout the year,” stated Craig M. Audet, ARNA’s VP of global regulatory affairs.

Source:

http://invest.arenapharm.com/releases.cfm

Financial Summary

ARNA reported total revenues of $2.08 million for the fourth quarter ended December 31, 2011, compared with total revenues of $4.01 million in the comparable quarter of 2010. For the full year, the Company reported total revenues of $12.72 million, compared with $16.61 million in the previous year.

Research and development expenses continued to decline to $13.1 million in the fourth quarter of 2011 from $16.5 million in the fourth quarter of 2010. Research and development expenses in the full year ended December 31, 2011, declined to $58.7 million from $75.5 million in the full year ended December 31, 2010. The Company attributed the decreases to its first quarter 2011 workforce reduction and ongoing cost-containment efforts, as well as completion of the Phase III lorcaserin clinical trials.

ARNA realized a net loss of $23.7 million, or $0.16 per share, for the quarter, compared to $28.2 million, or $0.23 per share, in the comparable quarter of the previous year. Including $10.5 million of non-cash debt extinguishment charges and $3.5 million of restructuring charges, ARNA’s net loss in the full year ended December 31, 2011, was $111.5 million, or $0.80 per share, compared to $124.5 million, or $1.14 per share, in the full year ended December 31, 2010, which included $12.4 million of non-cash debt extinguishment charges.

ARNA’s cash and cash equivalents totaled $57.6 million and approximately 146.1 million shares of common stock were outstanding at December 31, 2011.   In January 2012, the Company received net proceeds of approximately $27.9 million from its equity financing with certain Deerfield entities, after principal prepayment of $5.0 million on its Deerfield loan. In March 2012, the Company received net proceeds of approximately $24.7 million under an equity line of credit with Azimuth Opportunity L.P. After such financings, on March 14, 2012, approximately 180.4 million shares of common stock were outstanding.

Source:

http://invest.arenapharm.com/releasedetail.cfm?ReleaseID=657322

Technical Analysis

Source: http://stockcharts.com

ARNA is above the upper Bollinger Band, implying that it is currently extended from its recent trend. Be aware, however, that a cross outside of the Bollinger Bands can sometimes be a signal of trend strength and not, necessarily, trend reversal.

The MACD for ARNA currently indicates a strong bullish signal for two reasons. First, the MACD is above the signal line, a 9-day moving average. Second, the MACD is above 0, which implies that the underlying moving averages are trending higher.

Comparative Analysis

Source: Thomson Financial

DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND ON THIS REPORT. We are not registered as a securities broker-dealer or an investment adviser either with the U.S. Securities and Exchange Commission (the “SEC”) or with any state securities regulatory authority.  We are neither licensed nor qualified to provide investment advice.

The information contained in our report should be viewed as commercial advertisement and is not intended to be investment advice.  The report is not provided to any particular individual with a view toward their individual circumstances. The information contained in our report is not an offer to buy or sell securities.  We distribute opinions, comments and information free of charge exclusively to individuals who wish to receive them.

Our newsletter and website have been prepared for informational purposes only and are not intended to be used as a complete source of information on any particular company.  An individual should never invest in the securities of any of the companies profiled based solely on information contained in our report.  Individuals should assume that all information contained in the report about profiled companies is not trustworthy unless verified by their own independent research.

Any individual who chooses to invest in any securities should do so with caution.  Investing in securities is speculative and carries a high degree of risk; you may lose some or all of the money that is invested.  Always research your own investments and consult with a registered investment advisor or licensed stock broker before investing.

Information contained in our report will contain “forward looking statements” as defined under Section 27A of the Securities Act of 1933 and Section 21B of the Securities Exchange Act of 1934.  Subscribers are cautioned not to place undue reliance upon these forward looking statements.  These forward looking statements are subject to a number of known and unknown risks and uncertainties outside of our control that could cause actual operations or results to differ materially from those anticipated.  Factors that could affect performance include, but are not limited to, those factors that are discussed in each profiled company’s most recent reports or registration statements filed with the SEC.  You should consider these factors in evaluating the forward looking statements included in the report and not place undue reliance upon such statements.

We are committed to providing factual information on the companies that are profiled.  However, we do not provide any assurance as to the accuracy or completeness of the information provided, including information regarding a profiled company’s plans or ability to effect any planned or proposed actions.  We have no first-hand knowledge of any profiled company’s operations and therefore cannot comment on their capabilities, intent, resources, nor experience and we make no attempt to do so.  Statistical information, dollar amounts, and market size data was provided by the subject company and related sources which we believe to be reliable.

To the fullest extent of the law, we will not be liable to any person or entity for the quality, accuracy, completeness, reliability, or timeliness of the information provided in the report, or for any direct, indirect, consequential, incidental, special or punitive damages that may arise out of the use of information we provide to any person or entity (including, but not limited to, lost profits, loss of opportunities, trading losses, and damages that may result from any inaccuracy or incompleteness of this information).

We encourage you to invest carefully and read investment information available at the websites of the SEC at http://www.sec.gov and FINRA at http://www.finra.org.

Related Articles

1. Biotech Stock on Watch: Arena Pharmaceuticals Inc. (ARNA)
2. Stock Alert for Arena Pharmaceuticals Inc. (ARNA)
3. Stock Alert for BioSante Pharmaceuticals Inc. (BPAX)

Bank of America Corp. (BAC), a financial holding company, provides a full range of banking, investing, asset management and other financial and risk management products and services to individual consumers, small- and middle-market businesses and large corporations.  It serves approximately 57 million consumer and small business relationships with approximately 5,700 retail banking offices and approximately 17,750 ATMs and online banking with 30 million active users. BAC offers support to about four million small business owners through a suite of innovative, easy-to-use online products and services.  It serves clients through operations in more than 40 countries.

Source: Reuters.com, SEC Filings.

Investment Highlights

Shares in BAC inched up 0.81% to close at $9.93, extending gains into a second trading session. Over 240 million shares exchanged hands during the session, versus the 10-day average of over 444 million. The stock is currently below its 50-day moving average of $8.38 and above its 200-day moving average of $6.80. Market capitalization currently stands at $106.57 billion and it has 10.73 billion outstanding shares.

Shares in the banking giant have gained 4.2% in the last five days and 26.0% in the last month.  Year-to-date, the stock is down 25.6%.

Investors boosted shares in BAC on Monday as Motley Fool senior analyst Anand Chokkavelu speculated that stock could double to $20 a share — a level it hasn’t touched since November 2008.  Yesterday, the shares traded in the range of $9.85 to $10.04, compared to 52 -week range of $4.92 to $13.88.

In a video online, Chokkavelu discussed how it is possible for the stock price to achieve a 100% increase.

“With all the fanfare about Bank of America’s jump from $5 a share just a few months ago to around $10 now, Anand considers Bank of America’s prospects to double again to $20 a share. He determines that it’s not as far-fetched as you may think, barring any huge macro shocks. It will take a focus on the basics and some time, but Anand believes another double from here is quite possible.”

Source:

http://www.fool.com/investing/general/2012/03/24/how-bank-of-america-gets-to-20-a-share.aspx

Financial Summary

BAC reported net income of $2.0 billion, or $0.15 per diluted share, for the fourth quarter of 2011, reversing a year-ago net loss of $1.2 billion, or $0.16 per diluted share. Revenue, net of interest expense, on a fully taxable-equivalent (FTE) basis rose 11% to $25.1 billion.

For the full year, the Company reported net income of $1.4 billion, or $0.01 per diluted share, compared with a net loss of $2.2 billion, or $0.37 per diluted share in 2010. Revenue, net of interest expense, on an FTE basis declined 15 percent to $94.4 billion.

Source:

http://mediaroom.bankofamerica.com/phoenix.zhtml?c=234503&p=irol-news&nyo=0

Technical Analysis

Source: http://stockcharts.com

BAC is presently near its upper Bollinger Band. This suggests that it is at a high level relative to recent action.

The MACD for BAC currently indicates a strong bullish signal for two reasons. First, the MACD is above the signal line, a 9-day moving average. Second, the MACD is above 0, which implies that the underlying moving averages are trending higher.

Comparative Analysis

Source: Thomson Financial

DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND ON THIS REPORT. We are not registered as a securities broker-dealer or an investment adviser either with the U.S. Securities and Exchange Commission (the “SEC”) or with any state securities regulatory authority.  We are neither licensed nor qualified to provide investment advice.

The information contained in our report should be viewed as commercial advertisement and is not intended to be investment advice.  The report is not provided to any particular individual with a view toward their individual circumstances. The information contained in our report is not an offer to buy or sell securities.  We distribute opinions, comments and information free of charge exclusively to individuals who wish to receive them.

Our newsletter and website have been prepared for informational purposes only and are not intended to be used as a complete source of information on any particular company.  An individual should never invest in the securities of any of the companies profiled based solely on information contained in our report.  Individuals should assume that all information contained in the report about profiled companies is not trustworthy unless verified by their own independent research.

Any individual who chooses to invest in any securities should do so with caution.  Investing in securities is speculative and carries a high degree of risk; you may lose some or all of the money that is invested.  Always research your own investments and consult with a registered investment advisor or licensed stock broker before investing.

Information contained in our report will contain “forward looking statements” as defined under Section 27A of the Securities Act of 1933 and Section 21B of the Securities Exchange Act of 1934.  Subscribers are cautioned not to place undue reliance upon these forward looking statements.  These forward looking statements are subject to a number of known and unknown risks and uncertainties outside of our control that could cause actual operations or results to differ materially from those anticipated.  Factors that could affect performance include, but are not limited to, those factors that are discussed in each profiled company’s most recent reports or registration statements filed with the SEC.  You should consider these factors in evaluating the forward looking statements included in the report and not place undue reliance upon such statements.

We are committed to providing factual information on the companies that are profiled.  However, we do not provide any assurance as to the accuracy or completeness of the information provided, including information regarding a profiled company’s plans or ability to effect any planned or proposed actions.  We have no first-hand knowledge of any profiled company’s operations and therefore cannot comment on their capabilities, intent, resources, nor experience and we make no attempt to do so.  Statistical information, dollar amounts, and market size data was provided by the subject company and related sources which we believe to be reliable.

To the fullest extent of the law, we will not be liable to any person or entity for the quality, accuracy, completeness, reliability, or timeliness of the information provided in the report, or for any direct, indirect, consequential, incidental, special or punitive damages that may arise out of the use of information we provide to any person or entity (including, but not limited to, lost profits, loss of opportunities, trading losses, and damages that may result from any inaccuracy or incompleteness of this information).

We encourage you to invest carefully and read investment information available at the websites of the SEC at http://www.sec.gov and FINRA at http://www.finra.org.

Related Articles

1. Stock Alert for Bank of America Corp. (BAC)
2. Stock Alert for National Bank of Greece (NBG)
3. Stock Alert for LifeVantage Corp. (LFVN)

Sprint Nextel Corp. (S) offers a comprehensive range of wireless and wireline communications services bringing the freedom of mobility to consumers, businesses and government users. It served more than 52 million customers at the end of the second quarter of 2011 and is widely recognized for developing, engineering and deploying innovative technologies, including the first wireless 4G service from a national carrier in the United States; offering industry-leading mobile data services, leading prepaid brands including Virgin Mobile USA, Boost Mobile, and Assurance Wireless; instant national and international push-to-talk capabilities; and a global Tier 1 Internet backbone. The Company operates two reportable segments: Wireless and Wireline.

Source: Reuters.com, SEC Filings.

Investment Highlights

S dropped 5.2% in the last five trading days; though the stock gained 8.7% in the last month.  Year-to-date, the stock is down nearly 40%.

Share price of  the Overland Park, Kansas-based company stood at $2.74 Friday, remaining unchanged from the previous session.  Nearly 27 million shares exchanged hands during the session, versus the 10-day average of over 55 million.

S saw heavy trading earlier this month after the telecom giant said it canceled a spectrum hosting agreement with LightSquared. High quality global journalism requires investment. Under the agreement signed in June last year, S agreed to deploy and operate an LTE network using its ‘Network Vision’ infrastructure capable of utilizing the 1.6 GHz spectrum licensed to or available to LightSquared. The deal contained contingencies related to possible interference issues with LightSquared’s spectrum, including S’s right to terminate the agreement if certain conditions were not met by LightSquared.

S returned $65 million in prepayments LightSquared made to cover costs that were not ultimately incurred by the Company.

“Sprint has been and continues to be supportive of LightSquared’s business plans and appreciates the company’s efforts to find a resolution to the interference issues impacting its ability to offer service on the 1.6 GHz spectrum. However, due to these unresolved issues, and subject to the provisions of the agreement, Sprint has elected to exercise its right to terminate the agreement announced last summer. We remain open to considering future spectrum hosting agreements with LightSquared, should they resolve these interference issues, as well as other interested spectrum holders,” the Company said in a statement.

Source:

http://newsroom.sprint.com/news/

Financial Summary

S reported consolidated net operating revenues of $8.7 billion for its fourth quarter, a 5% increase from the fourth quarter of 2010 and the third quarter of 2011. The Company attributed the quarterly year-over-year and sequential improvements to higher wireless service and equipment revenue, which was offset by a reduction in wireline revenue.

The Company reported adjusted OIBDA (operating income/(loss) before depreciation and amortization) of $842 million for the quarter, compared to $1.3 billion for the fourth quarter of 2010 and $1.4 billion in the third quarter of 2011. The quarterly year-over-year decline was primarily due to higher equipment net subsidy and sales expense, higher wireless cost of service and lower wireline revenues, partially offset by higher postpaid and prepaid wireless service revenues. Sequentially, quarterly adjusted OIBDA declined primarily as a result of higher equipment net subsidy and sales expense, partially offset by higher postpaid wireless service revenues and lower wireless cost of service. Based on internal estimates, including incremental costs associated with iPhone sales, the combined impact of iPhone and Network Vision costs reduced fourth quarter adjusted OIBDA of $842 million by approximately $684 million.

S had free cash flow of $257 million for the quarter, compared to $913 million for the fourth quarter of 2010 and negative $273 million for the third quarter of 2011.

Source:

http://newsroom.sprint.com/article_display.cfm?article_id=2179=

Technical Analysis

Source: http://stockcharts.com

S is within its Bollinger Bands. This is a normal condition suggesting that it is neither overbought nor oversold relative to the recent levels.

S’s MACD is indicating a weak bearish signal. Although the indicator is above the critical level of 0, which implies that the underlying moving averages are bullish, the MACD has crossed below its 9minute moving average or signal line. This suggests that positive momentum has begun to slow.

Comparative Analysis

Source: Thomson Financial

DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND ON THIS REPORT. We are not registered as a securities broker-dealer or an investment adviser either with the U.S. Securities and Exchange Commission (the “SEC”) or with any state securities regulatory authority.  We are neither licensed nor qualified to provide investment advice.

The information contained in our report should be viewed as commercial advertisement and is not intended to be investment advice.  The report is not provided to any particular individual with a view toward their individual circumstances. The information contained in our report is not an offer to buy or sell securities.  We distribute opinions, comments and information free of charge exclusively to individuals who wish to receive them.

Our newsletter and website have been prepared for informational purposes only and are not intended to be used as a complete source of information on any particular company.  An individual should never invest in the securities of any of the companies profiled based solely on information contained in our report.  Individuals should assume that all information contained in the report about profiled companies is not trustworthy unless verified by their own independent research.

Any individual who chooses to invest in any securities should do so with caution.  Investing in securities is speculative and carries a high degree of risk; you may lose some or all of the money that is invested.  Always research your own investments and consult with a registered investment advisor or licensed stock broker before investing.

Information contained in our report will contain “forward looking statements” as defined under Section 27A of the Securities Act of 1933 and Section 21B of the Securities Exchange Act of 1934.  Subscribers are cautioned not to place undue reliance upon these forward looking statements.  These forward looking statements are subject to a number of known and unknown risks and uncertainties outside of our control that could cause actual operations or results to differ materially from those anticipated.  Factors that could affect performance include, but are not limited to, those factors that are discussed in each profiled company’s most recent reports or registration statements filed with the SEC.  You should consider these factors in evaluating the forward looking statements included in the report and not place undue reliance upon such statements.

We are committed to providing factual information on the companies that are profiled.  However, we do not provide any assurance as to the accuracy or completeness of the information provided, including information regarding a profiled company’s plans or ability to effect any planned or proposed actions.  We have no first-hand knowledge of any profiled company’s operations and therefore cannot comment on their capabilities, intent, resources, nor experience and we make no attempt to do so.  Statistical information, dollar amounts, and market size data was provided by the subject company and related sources which we believe to be reliable.

To the fullest extent of the law, we will not be liable to any person or entity for the quality, accuracy, completeness, reliability, or timeliness of the information provided in the report, or for any direct, indirect, consequential, incidental, special or punitive damages that may arise out of the use of information we provide to any person or entity (including, but not limited to, lost profits, loss of opportunities, trading losses, and damages that may result from any inaccuracy or incompleteness of this information).

We encourage you to invest carefully and read investment information available at the websites of the SEC at http://www.sec.gov and FINRA at http://www.finra.org.

Related Articles

1. Trade Alert for Sprint Nextel Corp. (S)
2. Stock Alert for Sprint Nextel Corp. (S)
3. Stock Alert for Sprint Nextel Corp. (S)

Sirius XM Radio Inc. (SIRI) is a New York-based satellite radio company that broadcasts more than 135 channels of commercial-free music, and premier sports, news, talk, entertainment, traffic, weather and data services to more than 21 million subscribers. The Company offers an array of content from many of the biggest names in entertainment, as well as from professional sports leagues, major colleges, and national news and talk providers. SiriusXM programming is available on more than 800 devices, including pre-installed and after-market radios in cars, trucks, boats and aircraft, smartphones and mobile devices, and consumer electronics products for homes and offices. SIRI programming is also available at siriusxm.com, and on Apple, BlackBerry and Android-powered mobile devices. It has arrangements with every major automaker and its radio products are available for sale at shop.siriusxm.com as well as retail locations nationwide.

Source: Reuters.com, SEC Filings.

Investment Highlights

Sirius XM Radio Inc. (SIRI) shares slipped 0.44% to close Friday trade at $2.26. The stock saw volume of over 15 million shares, versus the 10-day average of over 25 million.

SIRI share have gained 7.6% in the last month and 35.4% year-to-date.

SIRI and Toyota Motor Sales last week announced that they will offer a free three-month trial subscription to Sirius XM Satellite Radio with the purchase of Toyota and Scion Certified Used cars, giving customers access to commercial-free music, sports, news, talk entertainment and traffic and weather information.

“This offer gives customers buying Toyota Certified Used Vehicles and Scion Certified Pre-Owned Vehicles the world’s best audio entertainment available on the road, and we look forward to working with Toyota and Scion dealers to provide even more of their customers the opportunity to listen to SiriusXM when buying any Certified Used Vehicle equipped with a satellite radio from Toyota,” commented Joe Verbrugge, SIRI’s senior VP for automotive remarketing division.

The satellite radio giant also recently announced a partnership with Ashbury Automotive Group (NYSE: ABG) to provide the latter’s customers a three-month SiriusXM subscription on pre-owned vehicles with factory-installed satellite radios.

Ryun Pavlicek, Ashbury Automotive Group’s director of retail strategy, said Ashbury customers purchasing pre-owned vehicles with factory-installed satellite radio will have access to commercial-free music, and premier sports, news, talk, entertainment plus traffic and weather information broadcast by SIRI. “Enabling our customers to drive off our lots with 3 months of satellite radio is a value-added service we are excited to provide.”

Verbugge said SIR looks forward to working with Asbury’s 79 dealerships to further enhance the pre-owned vehicle buying experience.

Source:

http://investor.siriusxm.com/index.cfm

Financial Summary

SIRI reported revenue of $784 million for the fourth quarter of 2011, up 7% from $736 million for the fourth quarter of 2010.  Adjusted EBITDA came in at $167 million, an increase of 16% from $144 million reported in the comparable period of the previous year.

The Company posted a GAAP net income of $71 million, or $0.01 per diluted share, for the quarter, reversing the year-ago loss of $81 million, $0.02 per diluted share.

SIRI’s net subscriber additions in the quarter were 542,966, up 65% compared to the fourth quarter of 2010.  Net self-pay subscriber additions were 374,432, an increase of 7% versus the fourth quarter of 2010.

Subscriber acquisition cost (SAC) per gross subscriber addition was $55, a 5% improvement from the $58 reported in the fourth quarter of 2010.  Average self-pay monthly customer churn was 1.9%, in-line with the 1.9% reported in the fourth quarter of 2010.  New vehicle consumer conversion rate was 44%, compared to 45% in the fourth quarter of 2010.

SIRI generated free cash flow of $192 million for the last three months of 2011, an increase of 15% compared to $167 million reported in the comparable quarter of 2010.

SIRI in February backed its 2012 revenue guidance of about $3.3 billion and free cash flow of about $700 million. It expects its subscriber base to grow by nearly 1.3 million net subscribers and end the year at about 23.2 million.

Source:

http://finance.yahoo.com/news/SiriusXM-Reports-2011-Results-prnews-194509295.html?x=0

Technical Analysis

SIRI is within its Bollinger Bands. This is a normal condition suggesting that it is neither overbought nor oversold relative to the recent levels.

SIRI’s MACD is indicating a weak bearish signal. Although the indicator is above the critical level of 0, which implies that the underlying moving averages are bullish, the MACD has crossed below its 9minute moving average or signal line. This suggests that positive momentum has begun to slow.

Source: http://stockcharts.com

Comparative Analysis

Source: Thomson Financial

DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND ON THIS REPORT. We are not registered as a securities broker-dealer or an investment adviser either with the U.S. Securities and Exchange Commission (the “SEC”) or with any state securities regulatory authority.  We are neither licensed nor qualified to provide investment advice.

The information contained in our report should be viewed as commercial advertisement and is not intended to be investment advice.  The report is not provided to any particular individual with a view toward their individual circumstances. The information contained in our report is not an offer to buy or sell securities.  We distribute opinions, comments and information free of charge exclusively to individuals who wish to receive them.

Our newsletter and website have been prepared for informational purposes only and are not intended to be used as a complete source of information on any particular company.  An individual should never invest in the securities of any of the companies profiled based solely on information contained in our report.  Individuals should assume that all information contained in the report about profiled companies is not trustworthy unless verified by their own independent research.

Any individual who chooses to invest in any securities should do so with caution.  Investing in securities is speculative and carries a high degree of risk; you may lose some or all of the money that is invested.  Always research your own investments and consult with a registered investment advisor or licensed stock broker before investing.

Information contained in our report will contain “forward looking statements” as defined under Section 27A of the Securities Act of 1933 and Section 21B of the Securities Exchange Act of 1934.  Subscribers are cautioned not to place undue reliance upon these forward looking statements.  These forward looking statements are subject to a number of known and unknown risks and uncertainties outside of our control that could cause actual operations or results to differ materially from those anticipated.  Factors that could affect performance include, but are not limited to, those factors that are discussed in each profiled company’s most recent reports or registration statements filed with the SEC.  You should consider these factors in evaluating the forward looking statements included in the report and not place undue reliance upon such statements.

We are committed to providing factual information on the companies that are profiled.  However, we do not provide any assurance as to the accuracy or completeness of the information provided, including information regarding a profiled company’s plans or ability to effect any planned or proposed actions.  We have no first-hand knowledge of any profiled company’s operations and therefore cannot comment on their capabilities, intent, resources, nor experience and we make no attempt to do so.  Statistical information, dollar amounts, and market size data was provided by the subject company and related sources which we believe to be reliable.

To the fullest extent of the law, we will not be liable to any person or entity for the quality, accuracy, completeness, reliability, or timeliness of the information provided in the report, or for any direct, indirect, consequential, incidental, special or punitive damages that may arise out of the use of information we provide to any person or entity (including, but not limited to, lost profits, loss of opportunities, trading losses, and damages that may result from any inaccuracy or incompleteness of this information).

We encourage you to invest carefully and read investment information available at the websites of the SEC at http://www.sec.gov and FINRA at http://www.finra.org.

Related Articles

1. Stock Alert for Sirius XM Radio Inc. (SIRI)
2. Stock Alert for Sirius XM Radio Inc. (SIRI)
3. Stock Alert for Sirius XM Radio Inc. (SIRI)

Glu Mobile (GLUU) is a global developer and publisher of social mobile games for smartphone and tablet devices. Its unique technology platform enables its titles to be accessible to a broad audience of consumers all over the world – supporting iOS, Android, Windows Phone, Google Chrome and beyond. The Company is focused on bringing the best in social, freemium, cross-platform mobile gaming experiences to the mass market. GLUU is focused on creating compelling original IP and also partners with leading entertainment brands including Activision, Atari, Caesar’s and Fox. 

Source: Reuters.com, SEC Filings.

Investment Highlights

Shares in GLUU advanced $0.85, or 21.25%, to close Friday trade at $4.85.  Nearly 15 million shares exchanged hands during the session, versus the 10-day average of 1.46 million. Over the last 52 weeks, the stock has ranged from a high of $6.10 to a low of $1.80.

GLUU shares have risen 22.5% in the last five days; 20.4% in the last month; and 34.7% year-to-date.

GLUU earlier this month announced the addition of Android APK Expansion File technology to one of its most popular casual titles, Bug Village.  As stated by the Company, the addition of APK Expansion File technology should lead to a better user experience for Android gamers through a single game download from Google Play.

Niccolo de Masi, president and CEO of GLUU, commented that by adding Android APK Expansion File technology to Glu games on Android, the Company is eliminating the existing dual-step download process for its high production value games.” With Android APK Expansion File, users will be able to download Bug Village faster and with less friction jump right into the action.  Over the medium term we anticipate Android APK Expansion File increasing the take-up of Glu games on Google Play.”

de Masi went on to say that the Company has worked closely with Google since the inception of the Android platform and seen non-GAAP revenues grow 10x from full year 2010 to full year 2011.

With over 850,000 new Android devices reaching consumers every day and advancements like Android APK Expansion File technology, GLUU looks forward with confidence to continued Android revenue growth in 2012, he said.

Source:

http://finance.yahoo.com/news/glus-android-momentum-continues-first-133000912.html

Financial Summary

GLUU reported total GAAP revenue of $15.2 million for the fourth quarter of 2011, compared to $15.6 million in the fourth quarter of 2010. Total non-GAAP revenue was $20.1 million for the quarter, compared to $15.5 million in the comparable quarter of the previous year. Non-GAAP revenue excludes changes in deferred revenue. GAAP revenue for the latest reported quarter reflects a refinement in revenue recognition methodology for purchases of virtual currency and virtual goods. Deferred revenue increased from $0.8 million at the end of 2010 to $7.1 million at December 31, 2011.

The Company reported a GAAP net loss was $10.0 million for the fourth quarter of 2011, compared to a GAAP net loss of $4.9 million for the fourth quarter of 2010. Non-GAAP net loss was $1.4 million for the fourth quarter of 2011, compared to $1.1 million for the fourth quarter of 2010.

Source:

http://finance.yahoo.com/news/Glu-Reports-Fourth-Quarter-bw-916691742.html?x=0

Technical Analysis

Source: http://stockcharts.com

GLUU is above the upper Bollinger Band, implying that it is currently extended from its recent trend. Be aware, however, that a cross outside of the Bollinger Bands can sometimes be a signal of trend strength and not, necessarily, trend reversal.

The MACD for GLUU currently indicates a strong bullish signal for two reasons. First, the MACD is above the signal line, a 9-day moving average. Second, the MACD is above 0, which implies that the underlying moving averages are trending higher.

Comparative Analysis

Source: Thomson Financial

DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND ON THIS REPORT. We are not registered as a securities broker-dealer or an investment adviser either with the U.S. Securities and Exchange Commission (the “SEC”) or with any state securities regulatory authority.  We are neither licensed nor qualified to provide investment advice.

The information contained in our report should be viewed as commercial advertisement and is not intended to be investment advice.  The report is not provided to any particular individual with a view toward their individual circumstances. The information contained in our report is not an offer to buy or sell securities.  We distribute opinions, comments and information free of charge exclusively to individuals who wish to receive them.

Our newsletter and website have been prepared for informational purposes only and are not intended to be used as a complete source of information on any particular company.  An individual should never invest in the securities of any of the companies profiled based solely on information contained in our report.  Individuals should assume that all information contained in the report about profiled companies is not trustworthy unless verified by their own independent research.

Any individual who chooses to invest in any securities should do so with caution.  Investing in securities is speculative and carries a high degree of risk; you may lose some or all of the money that is invested.  Always research your own investments and consult with a registered investment advisor or licensed stock broker before investing.

Information contained in our report will contain “forward looking statements” as defined under Section 27A of the Securities Act of 1933 and Section 21B of the Securities Exchange Act of 1934.  Subscribers are cautioned not to place undue reliance upon these forward looking statements.  These forward looking statements are subject to a number of known and unknown risks and uncertainties outside of our control that could cause actual operations or results to differ materially from those anticipated.  Factors that could affect performance include, but are not limited to, those factors that are discussed in each profiled company’s most recent reports or registration statements filed with the SEC.  You should consider these factors in evaluating the forward looking statements included in the report and not place undue reliance upon such statements.

We are committed to providing factual information on the companies that are profiled.  However, we do not provide any assurance as to the accuracy or completeness of the information provided, including information regarding a profiled company’s plans or ability to effect any planned or proposed actions.  We have no first-hand knowledge of any profiled company’s operations and therefore cannot comment on their capabilities, intent, resources, nor experience and we make no attempt to do so.  Statistical information, dollar amounts, and market size data was provided by the subject company and related sources which we believe to be reliable.

To the fullest extent of the law, we will not be liable to any person or entity for the quality, accuracy, completeness, reliability, or timeliness of the information provided in the report, or for any direct, indirect, consequential, incidental, special or punitive damages that may arise out of the use of information we provide to any person or entity (including, but not limited to, lost profits, loss of opportunities, trading losses, and damages that may result from any inaccuracy or incompleteness of this information).

Related Articles

1. Stock Alert for Glu Mobile Inc. (GLUU)
2. Stock Alert for Glu Mobile Inc. (GLUU)
3. Stock Scan for the Day: GLUU

NeoMedia Technologies Inc. (NEOM) provides 2D mobile barcode technology and infrastructure solutions that enable the mobile barcode ecosystem worldwide. Its technology platform transforms mobile devices with cameras into barcode scanners, enabling a range of practical and engaging applications including consumer oriented advertising, mobile ticketing and couponing, and business-to-business commercial track and trace solutions. NEOM’s suite of products, services and extensive IP portfolio means it is the only provider able to offer customers a comprehensive end-to-end mobile code solution. The Company’s current customers include handset manufacturers, platform providers, brands agencies looking to offer pioneering mobile barcode solutions to their customer base.

Source: Reuters.com, SEC Filings.

Investment Highlights

Mobile barcode scanning services provider NEOM edged up 3.64% to close Thursday trade at $0.0337, with volume over 78 million shares traded.  Over the last 52 weeks, the stock has ranged from a low of $0.01 to a high of $0.23. Market capitalization currently stands at 14.96 million and it has 437.38 million outstanding shares.

Shares of NEOM have risen 58.2% in the last five days and 332.1% in the last month.  Year-to-date, the stock is down 11.3%.

NEOM shares saw heavy trading earlier this month after the company announced that the U.S. Patent and Trademark Office (USPTO) has awarded it a patent pertaining to the resolution of mobile barcodes, a market which it said has recently experienced explosive growth. The Company said the recently issued patent is part of an intellectual property portfolio that includes more than fifty issued and pending patent applications in this space.

NEOM CEO Laura Marriott commented that the Company is delighted that the USPTO has issued the ‘597 patent, which combined with its already formidable patent portfolio, continues to allow the Company to realize the potential of its innovations and the first class services it offers its partners.

Also recently, the Company announced the launch of its updated NeoReader® barcode-scanning software applications for Apple iOS, Android, BlackBerry, Symbian and Windows Phone 7 users, enabling users to transform their devices into barcode scanners and seamlessly connect to mobile content.

NEOM states that NeoReader bridges the gap between traditional and digital media, allowing all users with camera phones to scan both 2D and 1D code types in order to access specific web content, real-time product or service information, download content, or complete a mobile commerce transaction with one click. Users no longer need to type in long URLs, scroll through long lists of search results or navigate cumbersome mobile phone menus.

NEOM in February named Colonel Barry S. Baer as its new CFO. He has served as both CFO and CEO to a wealth of public, privately held and not for profit companies and prior to this served as an officer in the U.S. Army for 27 years, retiring at the rank of colonel.

“The next 12 months will be a time of critical growth for NeoMedia and with the addition of Barry to our leadership team, we are more confident than ever that we will deliver strong financial results and increase shareholder value,” commented CEO Marriott.

Source:

http://www.neom.com/press/press_releases

Financial Summary

NEOM reported revenues of $528K for the three months ended September 2011, up 56% from $338K reported in the three months ended September 2010. The Company had loss from operations of $1.3 million for the quarter, compared to loss from operations of $1.4 million in the comparable quarter of the prior year.

The Company saw a net income of $59.4 million for three months ended September 2011, compared with a net loss of $25.6 million in the same quarter in the previous year. The Company attributed the increase in net income to gains in the fair value of its hybrid and derivative instruments during the three months ended September 2011, compared with a loss in the previous year.

As of September 30, 2011, the Company had $250K in cash and cash equivalents, up 213% from $80K at December 31, 2010.

Source:

http://biz.yahoo.com/e/111114/neom.ob10-q.html?legacy=1

Technical Analysis

Source: http://stockcharts.com

NEOM is presently near its upper Bollinger Band. This suggests that it is at a high level relative to recent action.

The MACD for NEOM currently indicates a strong bullish signal for two reasons. First, the MACD is above the signal line, a 9-day moving average. Second, the MACD is above 0, which implies that the underlying moving averages are trending higher.

Comparative Analysis

Source: Thomson Financial

DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND ON THIS REPORT. We are not registered as a securities broker-dealer or an investment adviser either with the U.S. Securities and Exchange Commission (the “SEC”) or with any state securities regulatory authority.  We are neither licensed nor qualified to provide investment advice.

The information contained in our report should be viewed as commercial advertisement and is not intended to be investment advice.  The report is not provided to any particular individual with a view toward their individual circumstances. The information contained in our report is not an offer to buy or sell securities.  We distribute opinions, comments and information free of charge exclusively to individuals who wish to receive them.

Our newsletter and website have been prepared for informational purposes only and are not intended to be used as a complete source of information on any particular company.  An individual should never invest in the securities of any of the companies profiled based solely on information contained in our report.  Individuals should assume that all information contained in the report about profiled companies is not trustworthy unless verified by their own independent research.

Any individual who chooses to invest in any securities should do so with caution.  Investing in securities is speculative and carries a high degree of risk; you may lose some or all of the money that is invested.  Always research your own investments and consult with a registered investment advisor or licensed stock broker before investing.

Information contained in our report will contain “forward looking statements” as defined under Section 27A of the Securities Act of 1933 and Section 21B of the Securities Exchange Act of 1934.  Subscribers are cautioned not to place undue reliance upon these forward looking statements.  These forward looking statements are subject to a number of known and unknown risks and uncertainties outside of our control that could cause actual operations or results to differ materially from those anticipated.  Factors that could affect performance include, but are not limited to, those factors that are discussed in each profiled company’s most recent reports or registration statements filed with the SEC.  You should consider these factors in evaluating the forward looking statements included in the report and not place undue reliance upon such statements.

We are committed to providing factual information on the companies that are profiled.  However, we do not provide any assurance as to the accuracy or completeness of the information provided, including information regarding a profiled company’s plans or ability to effect any planned or proposed actions.  We have no first-hand knowledge of any profiled company’s operations and therefore cannot comment on their capabilities, intent, resources, nor experience and we make no attempt to do so.  Statistical information, dollar amounts, and market size data was provided by the subject company and related sources which we believe to be reliable.

To the fullest extent of the law, we will not be liable to any person or entity for the quality, accuracy, completeness, reliability, or timeliness of the information provided in the report, or for any direct, indirect, consequential, incidental, special or punitive damages that may arise out of the use of information we provide to any person or entity (including, but not limited to, lost profits, loss of opportunities, trading losses, and damages that may result from any inaccuracy or incompleteness of this information).

We encourage you to invest carefully and read investment information available at the websites of the SEC at http://www.sec.gov and FINRA at http://www.finra.org.

Related Articles

1. Penny Stock on Watch: NeoMedia Technologies Inc. (NEOM)
2. Penny Stock Spotlight: NeoMedia Technologies Inc. (NEOM) Gives Up Gains
3. Stock Alert for NeoMedia Technologies Inc. (NEOM)